hims compounded glp-1 & Hers stock drops 30% after Novo Nordisk terminates deal Hims cancels plans to sell

doi: 10.2337/diabetes.53.suppl_3.s16 131 WuF.GuoX.ZhangM.OuZ.WuD.DengL.et al

Her work has appeared on websites inc

Were seeing many individuals in Brisbane and beyond who are looking for ways to complement their GLP-1 therapy with a diet that ensures nutrient adequacy while promoting fat loss and preserving muscle

Zvibel, C

We observed that despite both groups consuming a dose of alcohol calculated to raise blood alcohol to 0.1 g/dl (approximately 0.08 g/dl BrAC) 51,52 participants in the GLP-1RA group showed a slowed rise in BrAC and altered the subjective effects of alcohol

Note: Europe might benefit here before the US because the US incentivizes pharma companies to update devices with novel solutions'' to extend patent protection (e.g., Epi-pen)